e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Problems in intensive care medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protocol based approacment in severe sepsis: one year experience
Z. Karakurt, T. Yarkin, N. Adigüzel, G. Güngör, O. Sogukpinar, E. Acartürk (Istanbul, Turkey)
Source:
Annual Congress 2007 - Problems in intensive care medicine
Session:
Problems in intensive care medicine
Session type:
Thematic Poster Session
Number:
3453
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Karakurt, T. Yarkin, N. Adigüzel, G. Güngör, O. Sogukpinar, E. Acartürk (Istanbul, Turkey). Protocol based approacment in severe sepsis: one year experience. Eur Respir J 2007; 30: Suppl. 51, 3453
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Related content which might interest you:
Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017
Improvement in process-of-care and outcome after a multicenter educational program for severe sepsis: the surviving sepsis campaign in Spain
Source: Annual Congress 2008 - Diagnosis and outcome in critically ill patients
Year: 2008
Evolution of acute respiratory failure in medical and surgical septic patients: a 5 years retrospective study
Source: International Congress 2017 – From respiratory muscles to acute respiratory failure
Year: 2017
Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR)
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
Characteristics of severe asthma in China with one year follow-up: the C-BIOPRED study
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Impact of six week hospital based Pulmonary Rehabilitation programme in patients with post Pulmonary Tuberculosis sequelae: Initial results from a hospital based longitudinal study
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020
Late-breaking abstract: Improvements in compliance of resuscitation bundles and achievement of end points after an educational program on the management of severe sepsis and septic shock
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011
Omalizumab in severe uncontrolled asthma: two and a half year clinical experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
How to protect children from the risk of tuberculosis disease? The contact study. Management suggestions based on a 11 year experience
Source: Eur Respir J 2002; 20: Suppl. 38, 549s
Year: 2002
Impact of early antibiotics on severe sepsis – are we doing a good job?
Source: Eur Respir J 2007; 30: Suppl. 51, 52s
Year: 2007
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
Three practical case studies on COPD using a remote voting system: 2. At hospital: NIV for acute exacerbation of COPD
Source: Annual Congress 2013 –Management of COPD with NIV
Year: 2013
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
Episodic home interventions in bedridden chronic respiratory failure patients: a 3 year survey
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008
Development of asthma-related symptoms in mild or moderate COVID-19 patients several months post infection: A descriptive case series from a pneumologist outpatient clinic
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
Are patients who report persistent symptoms and days lost due to asthma more likely to be hospitalised in the subsequent year?
Source: Eur Respir J 2002; 20: Suppl. 38, 204s
Year: 2002
Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept